EligibleTrials

Metronidazole: clinical trials recruiting now

5
Recruiting trials
7
Conditions studied
3
US states with sites
3
Countries

FDA drug label

FDA-approved
Yes. Metronidazole appears in the FDA drug-label database. Marketed as Metronidazole.
Drug class
Nitroimidazole Antimicrobial (FDA established pharmacologic class)
Boxed warning
The FDA label for Metronidazole carries a boxed warning (the FDA's most serious warning). See the full label for details.

FDA-approved use

Symptomatic Trichomoniasis. Metronidazole tablets are indicated for the treatment of T. vaginalis infection in females and males when the presence of the trichomonad has been confirmed by appropriate laboratory procedures (wet smears and/or cultures). Asymptomatic Trichomoniasis. Metronidazole tablets are indicated in the treatment of asymptomatic T. vaginalis infection in females when the organism is associated with endocervicitis, cervicitis, or cervical erosion. Since there is evidence that presence of the trichomonad can interfere with accurate assessment of abnormal cytological smears, additional smears should be performed after eradication of the parasite. Treatment of Asymptomatic Sexual Partners. T. vaginalis infection is a venereal disease. Therefore, asymptomatic sexual partners of treated patients should be treated simultaneously if the organism has been found to be present, in order to prevent reinfection of the partner. The decision as to whether to treat an asymptomatic male partner who has a negative culture or one for whom no culture has been attempted is an individual one. In making this decision, it should be noted that there is evidence that a woman may become re…

FDA recalls / enforcement

Reason (FDA)ClassificationStatusInitiated
Presence of Particulate Matter: identified as a cloth fiber. — Baxter Healthcare Corp. Class I (FDA: reasonable probability of serious harm or death) Terminated 2016-01-21
Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port. — Baxter Healthcare Corp. Class II (FDA: may cause temporary or reversible harm) Terminated 2013-05-21

FDA label via openFDA

Phase breakdown

Phase 2 4 Phase 4 1

Conditions being studied

ConditionTrials
Colorectal cancer2
Pancreatic Cancer2
Metastatic Prostate Cancer1
Prostate Cancer (Adenocarcinoma)1
Prostate cancer1
Rectal Adenocarcinoma1
Rectal Cancer, Adenocarcinoma1

Recruiting trials involving Metronidazole

Common questions

Is Metronidazole FDA-approved?

Yes, marketed as Metronidazole. Its FDA label carries a boxed warning.

How many recruiting trials involve Metronidazole?

5 recruiting trials across 7 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.